Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host intestinal epithelial receptors for Enterotoxigenic Escherichia coli (ETEC) colonization factors (CFs) are a diverse set of cell-surface molecules that mediate the initial attachment of the pathogen to the host gut mucosa. These receptors primarily consist of glycoproteins and glycosphingolipids, with the carcinoembryonic antigen-related cell adhesion molecule (CEACAM) family—specifically CEACAM1, CEACAM5, and CEACAM6—serving as critical binding sites for class 5 fimbriae such as CFA/I (Korotkova et al., 2008, J Biol Chem). Other ETEC colonization factors recognize carbohydrate moieties on blood group antigens, including H-type 1 and Lewis antigens, as well as specific glycolipids like sulfatide and GM1 (Fleckenstein et al., 2014, Biochim Biophys Acta). This adherence is essential for ETEC to resist peristaltic clearance, allowing the bacteria to colonize the small intestine and secrete enterotoxins that cause watery diarrhea (Madhavan et al., 2021, Front Cell Infect Microbiol). Consequently, these host receptors are significant targets for anti-adhesive therapeutic strategies, including the use of receptor-mimicking decoys, glycomimetic inhibitors, and vaccines designed to block the CF-receptor interface (Moonens et al., 2015, Nature Communications). Understanding the specificity of these interactions is vital for developing broad-spectrum interventions against the various ETEC strains that contribute to global diarrheal disease.
Competitive inhibition of the binding between bacterial colonization factors (fimbriae/pili) and host intestinal epithelial receptors (glycoproteins/glycolipids), preventing bacterial colonization and subsequent toxin delivery.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host intestinal epithelial receptors for Enterotoxigenic Escherichia coli colonization factors (ETEC CF receptors).